StockNews.com cut shares of Vertex Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 21st. Finally, Canaccord Genuity Group boosted their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback